Tech Company Financing Transactions
CBC Biotechnologies Funding Round
CBC Biotechnologies, based in Tampa, secured $7 million in investment from Tuatara Capital and private investors.
Transaction Overview
Company Name
Announced On
3/9/2016
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Tuatara Capital (Lead Investor) (Robert Hunt)
Proceeds Purpose
Tuatara's substantial funding further enables CBCBio's commitment to delivering cost effective, pharmaceutically pure cannabinoids in support of medical research, product development and implementation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12005 Whitmarsh Ln.
Tampa, FL 33626
USA
Tampa, FL 33626
USA
Phone
Website
Email Address
Overview
A global leader in the use of synthetic biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Korentur
Browse more venture capital transactions:
Prev: 3/9/2016: CloudCover venture capital transaction
Next: 3/9/2016: Celigo venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs